F.D.A. Expected to Soon Clear Pfizer Booster for Children Ages 5 to 11 Given that the age group has the lowest coronavirus vaccination rate of all eligible Americans, public health experts are not expecting a rush for the booster.
F.D.A. Sets Aside June for Potential Decisions on Vaccines for Children Under 5 Both Moderna and Pfizer-BioNTech have asked the agency to approve their vaccines for the youngest children.
Scientists Question Data Behind an Experimental Alzheimer’s Drug Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.
Bill Gates: We Must Develop Drugs Much Faster in the Next Pandemic The more rapidly we are able to produce safe, effective drugs for quick-spreading pathogens like the coronavirus, the more lives we can save.